Search Results
Oct 14, 2025, 09:00 ET Grow Therapy Names New Leaders in Marketing, Data & Design to Power Next Chapter
high-quality and affordable mental health care accessible to everyone addresses one of the most pressing issues of our time," said Ball. "I believe we have a rare opportunity to build a widely recognized and beloved brand that breaks from what people expect of the category, moves people, and makes a meaningful
More news about: Grow Therapy
Oct 14, 2025, 09:00 ET Mounting Pressures Demand Faster Action on Leave Management Practices and Policy Modernization, According to NFP Research
employees experiencing menopause symptoms. "While some accommodations are gaining traction, comprehensive menopause support remains rare," said Trapenasso. "The costs of inaction are real. Unmanaged symptoms can create productivity loss, disengagement and erosion of performance. Employers
More news about: NFP Corp.
Oct 14, 2025, 09:00 ET Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025
Genomics will host a DNBSEQ™ User Group Meeting to bring together researchers and customers to share best practices, explore applications across oncology, rare disease and population genomics, and hear updates from the company on product innovations. The meeting will take place on Tuesday, Oct. 14, 2025,
More news about: Complete Genomics
Oct 14, 2025, 08:53 ET Kēvens Earns Grammy Consideration for 'Call To Balance' in Album of the Year and Global Album of the Year Categories
Born in Miami's vibrant club scene and mentored by Cedella Marley Booker, mother of reggae legend Bob Marley, Kēvens' career reflects a rare synthesis of heritage and innovation. From his early days performing with the Marley family's Le Coup to sharing stages with icons like Steven Tyler,
More news about: Kēvens
Oct 14, 2025, 08:42 ET Step Inside the Entrepreneur Organization Experience
founders and owners are invited to experience the power of the Entrepreneurs' Organization (EO) for a day hosted by the EO Baltimore Chapter. This offers a rare opportunity to step inside a global community of entrepreneurs who learn and grow together. The
More news about: Entrepreneurs' Organization Baltimore
Oct 14, 2025, 08:35 ET Locksley Appoints Former U.S. Airforce Major General & General Dynamics IT Executive to Advisory Board
/PRNewswire/ -- Locksley Resources (ASX: LKY; OTCQX: LKYRF), the company focused on critical minerals with their Mojave Project in California targeting rare earth elements (REEs) and antimony, today announced the appointment of Major General (Ret.) Peter J. Lambert to the company's Advisory Board. He brings
More news about: Locksley Resources
Oct 14, 2025, 08:34 ET 100% Women-Owned Happenstance Whiskey Introduces Limited-Release Single Barrel
(BTI) delivers classic baking spices on the nose and palate, with warm, embracing honey notes on the finish. "I hand-picked these rare barrels to expand our premium whiskey selection. I'm really excited about this new release and think it complements our current portfolio perfectly,"
More news about: Happenstance Whiskey
Oct 14, 2025, 08:18 ET BERA.ai and The CMO Podcast with Jim Stengel Launch The Brand Builder's Playbook: A New Podcast for CMOs Navigating the Future of Marketing
prove impact, align with CEOs and CFOs, and deliver both short-term ROI and long-term enterprise value. The Brand Builder's Playbook offers a rare, unfiltered glimpse into how those decisions are made. "Marketers are sort of deer in the headlights right now," said Jim Stengel.
More news about: BERA.ai
Oct 14, 2025, 08:00 ET Orsini Selected as Specialty Pharmacy Partner for Boehringer Ingelheim's JASCAYD® (nerandomilast)
care since 1987, Orsini is a leader in rare diseases and gene therapies. Orsini partners with biopharma innovators, healthcare providers and payors to support patients and their families in accessing revolutionary treatments for rare diseases. Through integrated rare disease pharmacy solutions including
More news about: Orsini
Oct 14, 2025, 08:00 ET Agentic Summit: A Convergence of Tokenization, AI, and Global Capital in the UAE
TRUF.NETWORK by Truflation, and Anton Golub (RWA Labs). Agentic. will give attendees unsurpassed and rare insight into how global capital flows are being reshaped. Attendance is open to all actively involved in tokenization, market infrastructure, digital
More news about: MANTRA Chain
Oct 14, 2025, 08:00 ET Agentic Summit: A Convergence of Tokenization, AI, and Global Capital in the UAE
TRUF.NETWORK by Truflation, and Anton Golub (RWA Labs). Agentic. will give attendees unsurpassed and rare insight into how global capital flows are being reshaped. Attendance is open to all actively involved in tokenization, market infrastructure,
More news about: MANTRA Chain
Oct 14, 2025, 07:30 ET Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today the update of its United States (U.S.) Medical Advisory Board (MAB) for cutaneous T-cell
More news about: Soligenix
Oct 14, 2025, 07:13 ET Brogidirsen (NS-089/NCNP-02) 3.5 Year Clinical Trial Data for the Treatment of Duchenne Muscular Dystrophy Presented at 2025 World Muscle Society Congress
PARAMUS, N.J., Oct. 14, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a biopharmaceutical leader in rare disease and subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that the National Center of Neurology and Psychiatry (NCNP, Kodaira
More news about: NS Pharma, Inc.
Oct 14, 2025, 07:10 ET Final analysis of open-label extension (OLE) study of FINTEPLA® (fenfluramine) in Lennox-Gastaut syndrome published in Epilepsy & Behavior
About Lennox-Gastaut syndrome (LGS) Lennox-Gastaut syndrome (LGS) is a rare, severe developmental and epileptic encephalopathy (DEE) characterized by the presence of tonic seizures and at least one additional seizure type and
More news about: UCB
Oct 14, 2025, 07:00 ET Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day
(CKD)).1,2 HRS is estimated to affect more than 60,000 Americans annually, approximately 0.01% of the U.S. population,3 making it a rare condition; and rates of HRS hospitalizations are increasing.4 "We're proud to support this moment for the HRS community
More news about: Mallinckrodt plc
Oct 14, 2025, 07:00 ET CHICAGO VENTURE SUMMIT FUTURE OF FOOD RETURNS WITH BOLD FOCUS ON INNOVATION & SUSTAINABILITY
shaping the future of food. With Chicagoland recognized as the #1 food manufacturing hub in the U.S., the sold-out Summit offers media and industry a rare look inside one of the world's most dynamic food and agtech ecosystems. To learn more, visit
More news about: World Business Chicago
Oct 14, 2025, 00:30 ET The Science of Good Health Introduces Curated Line of Supplements
Why Choose The Science of Good Health: Each product from The Science of Good Health reflects a rare balance of purity, potency, and purpose. The brand's formulations are built on years of clinical experience and grounded in scientific research.
More news about: The Science of Good Health
Oct 13, 2025, 16:11 ET Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
independence; it is a declaration that he will lead by example. In an era when public trust is at an all-time low, his approach signals a return to something rare in politics; principled leadership that puts the people first. "The people of this state are hungry for authenticity," McLeod
More news about: Mullins McLeod
Oct 13, 2025, 15:42 ET Gemstones Market to Reach USD 101.01 Billion by 2032, Growing At An 6.3% CAGR - Credence Research
three" of rubies, sapphires, and emeralds, with consumers seeking rare and distinctive stones including spinel, tanzanite, and tourmaline. Market data from the 2025 Tucson gem shows indicates focused buying activity concentrated on high-end rare goods, with particular demand for vibrant green and orange-red
More news about: Credence Research Inc.
Oct 13, 2025, 14:34 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers - SVRA
the class action] Savara is a clinical-stage biopharmaceutical company focused on rare respiratory diseases. The Company's lead product candidate is MOLBREEVI (also referred to as "molgramostim"), an inhaled granulocyte-macrophage colony-stimulating
More news about: Pomerantz LLP
Oct 13, 2025, 14:05 ET Kelley Blue Book Report: New-Vehicle Average Transaction Price Hits Record High in September, Surges Past $50,000 for the First Time Ever
more than 60 models with ATPs above $75,000 with total sales near 94,000 units – 7.4% of total industry sales, up from 6.0% in September 2024. In the rare air of six-figure vehicles, the Cadillac Escalade is still king. Two versions are available, with total sales in September reaching 4,320 units.
More news about: Kelley Blue Book
Oct 13, 2025, 13:00 ET Camera West Opens Flagship SoHo Location, Uniting Online and In-Store Experiences Through Shopify
For over 25 years, Camera West has served as a haven for photographers, collectors, and creators seeking rare and high-performance equipment from the world's most respected brands including Leica, Hasselblad, Fujifilm and more. With flagship locations in San
More news about: P3 Media
Oct 13, 2025, 11:11 ET PANTHERx® Rare Selected by Chiesi for the Distribution of MYCAPSSA®
About PANTHERx Rare PANTHERx Rare is a specialty pharmacy exclusively focused on rare and orphan diseases, distributing several orphan products and providing access and support services to those needing them most. Known as The Rare Disease Pharmacy®,
More news about: PANTHERx Rare Pharmacy
Oct 13, 2025, 11:00 ET Natural Field Drives Breakthroughs in Co-loading Liposome Technology, Accelerating Upgrading of Raw Materials for Cardiovascular and Gut Health
stability during storage and in-vivo transportation. Synergistic Efficacy Potential: The combination of rare ginsenosides with CoQ10 and curcumin not only enhances membrane stability but also co-loads more active ingredients. For example, it meets the synergistic
More news about: Natural Field
Oct 13, 2025, 09:30 ET NORD Breakthrough Summit Features Bold New Ideas for the Future of Rare Disease Care, Policy and Research
WASHINGTON, Oct. 13, 2025 /PRNewswire/ -- The future of rare disease advancements will take center stage at the National Organization for Rare Disorders (NORD®) Rare Disease and Orphan Products Breakthrough Summit®, Oct. 19-21 in Washington.
More news about: National Organization for Rare Disorders (NORD®)